January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …


Install CouponFollow Chrome Extension   CouponFollow Extension

$50
OFF

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

1 week from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio …

prnewswire.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

yahoo.com

$50
OFF

Ratio Therapeutics Secures $50M Series B To Develop Cancer …

1 week from now

Jan 18, 2024  · Photo: Shutterstock. Boston-based pharmaceutical company Ratio Therapeutics has announced the completion of a $50 million Series B financing round to advance its …

builtinboston.com

$50
OFF

Ratio Therapeutics Raises $50M For Tumor-targeting …

1 week from now

Jan 17, 2024  · Ratio announced its $50M Series B financing Wednesday. Investors in this round of capital included Series A leads Duquesne Capital and Schusterman Family Investments, as …

bizjournals.com

$50
OFF

Ratio Therapeutics Raises $50M In Series B Financing

1 week from now

Jan 17, 2024  · Ratio Therapeutics Raises $50M in Series B Financing Jan 17, 2024 ... NEW YORK – Ratio Therapeutics on Wednesday announced that it has raised $50 million in a …

precisionmedicineonline.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To

1 week from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio …

biospace.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

epicos.com

$50
OFF

January 17, 2024 - Ratio Therapeutics

1 week from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

$50
OFF

Boston's Ratio Therapeutics Raises $50M Series B For R&D

1 week from now

Pharmaceutical startup Ratio Therapeutics has raised a fresh round of funding, the company announced Wednesday, closing on a $50 million Series B round that will be used to expand its …

law360.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment PR Newswire BOSTON, Jan. 17, 2024 Boston-Based...

marketwatch.com

$50
OFF

News - Ratio Therapeutics

1 week from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

$50000000
OFF

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

1 week from now

Jan 17, 2024  · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted …

crunchbase.com

$50
OFF

Ratio Therapeutics Secures Funds For Cancer Radiotherapies

1 week from now

Jan 18, 2024  · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …

pharmaceutical-technology.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, MA, USA I January 17, 2024 I Ratio …

pipelinereview.com

$50
OFF

Ratio Therapeutics Scores $50M Series B - VC News Daily

1 week from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

vcnewsdaily.com

$50
OFF

Ratio Raises Series B To Advance Radiotherapeutic Into Clinic

1 week from now

Jan 19, 2024  · Ratio Therapeutics Inc. has closed a $50 million series B financing to expand application of its proprietary technology platforms, Trillium and Macropa, to develop novel best …

bioworld.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

1 week from now

BOSTON, January 17, 2024-- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for …

vcaonline.com

$50
OFF

Ratio Raises $50M As Radiopharma Field Finds Its Groove

1 week from now

Jan 17, 2024  · Radiopharmaceutical biotech Ratio Therapeutics has raised a $50 million Series B to bring its first therapeutic into the clinic, it said Wednesday morning. The biotech has now …

endpts.com

FAQs about January 17th, 2024: Ratio Therapeutics Announces $50M Series B ... Coupon?

Who backed ratio's $50M Series B financing?

Ratio announced its $50M Series B financing Wednesday. Investors in this round of capital included Series A leads Duquesne Capital and Schusterman Family Investments, as well as new backers PagsGroup, Bristol Myers Squibb and the Center for Technology Licensing at Cornell University. ...

Will ratio Therapeutics move its first drug candidate into clinical trials?

Ratio Therapeutics Inc. has secured the backing to move its first drug candidate into clinical trials by the end of this year. The Boston company is developing radiopharmaceuticals for the treatment and monitoring of cancers. ...

What is ratio & how does it work?

Ratio was launched in 2021 by serial entrepreneurs Jack Hoppin and John Babich, who are behind companies like Invicro and Noria Therapeutics Inc. Radiation is often a common part of cancer treatment that involves using a beam of energy to kill cancer cells. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension